Last updated 2026-07-27
TL;DR
Most compounded enclomiphene protocols run 12.5mg to 25mg daily, taken orally, sometimes every other day. There's no FDA-approved dose because enclomiphene never won approval as a standalone drug. Dosing comes from clinical trial data on the discontinued Androxal program and from prescriber experience, not an official label.
What is the standard enclomiphene dosage?
Most men on compounded enclomiphene take somewhere between 12.5mg and 25mg per day, usually in the morning, with or without food. Some prescribers write it as an every-other-day dose in the same range once testosterone stabilizes. There is no manufacturer's label to point to here, because enclomiphene has never been FDA-approved as a standalone drug. Every dose you'll see quoted, including this one, comes from clinical trial protocols or from what compounding prescribers have converged on over the past decade. The closest thing to an official dosing precedent is the Androxal development program run by Repros Therapeutics. Their Phase III trials tested 12.5mg and 25mg daily doses in men with secondary hypogonadism [1]. Repros never got the drug across the finish line. The company's own trial registration and later corporate filings confirm the program ended without an FDA approval, and Repros dissolved in 2018 [2]. So when a compounding pharmacy or clinic tells you '12.5 to 25mg daily,' they are echoing that old dose-ranging work, not quoting an approved label. Because every enclomiphene product on the market is compounded, doses aren't standardized the way a generic tablet's would be. One pharmacy's 12.5mg capsule and another's liquid titration might behave slightly differently depending on formulation and fillers. That's a real limitation of buying compounded medication, and worth sitting with before you assume the number on your bottle means the same thing everywhere.
How does enclomiphene dosing compare to clomiphene dosing?
| Enclomiphene | 12.5-25mg daily | Not approved (Androxal program discontinued) [2] | Trans-isomer only | |
|---|---|---|---|---|
| Clomiphene citrate | 25-50mg daily or EOD, off-label in men | Approved for female infertility only [4] | Mix of enclomiphene + zuclomiphene | If you're comparing the two head to head for TRT purposes, the honest answer is that direct comparative trials in men are thin. Most of what circulates online is extrapolated from separate small studies, not a single trial putting them side by side at matched doses. |
Clomiphene citrate is a mixture of two isomers, enclomiphene and zuclomiphene, and only enclomiphene is thought to do most of the testosterone-raising work. Zuclomiphene has a much longer half-life and accumulates with repeated dosing, which is part of why clomiphene carries more concern about mood and visual side effects over time [3]. Standard off-label clomiphene dosing for male hypogonadism runs 25mg to 50mg daily or every other day, a number pulled from urology literature rather than an FDA label (clomiphene is approved for female infertility, not for men) [4]. Enclomiphene doses tend to look lower on paper, 12.5 to 25mg, partly because it's the isolated active isomer and partly because trial sponsors were chasing a cleaner side effect profile than clomiphene's. | Compound | Typical dose range | FDA approval status | Isomer content |
How often should you take enclomiphene, daily or every other day?
Daily dosing is the more common starting point, largely because that's how the Androxal trials were structured [1]. Some prescribers move patients to every-other-day dosing once labs show testosterone has stabilized in range, on the logic that it reduces total monthly exposure without giving up much effect. There isn't strong published evidence settling this question either way for enclomiphene specifically. What we do know: enclomiphene's half-life estimates in available pharmacokinetic data run in the range of roughly 10 hours based on early studies, though estimates vary and this figure isn't nailed down with the same precision an approved drug would have. For a deeper look at what that means for dosing frequency, see Enclomiphene Direct half life. In practice, the every-other-day approach is more of a clinical judgment call than a protocol backed by a dedicated trial. If your levels look stable and your prescriber wants to try stretching the interval, that's a reasonable conversation to have. It's not something to decide on your own without follow-up labs.
How is enclomiphene actually taken, oral pills or injections?
Enclomiphene is fundamentally an oral compound. The vast majority of compounded enclomiphene comes as a capsule or oral solution taken by mouth, once a day. That's how it was studied in the Androxal trials and it's how most compounding pharmacies dispense it [1]. You may see injectable formulations offered by some compounding pharmacies, but this isn't the standard route and isn't what the clinical trial data was built on. If you're used to TRT injection routines, this is one of the real practical differences: no needles, no injection site rotation, no reconstitution. If you do want to understand injection technique for other compounds in your protocol, Enclomiphene Direct how to inject and Enclomiphene Direct injection sites cover that separately, but for enclomiphene itself, oral is the norm. Because it's oral and compounded, some pharmacies dispense it as a powder or liquid that needs mixing. If your prescription arrives that way, how to reconstitute Enclomiphene Direct walks through that process, and a dosage calculator can help you convert a liquid concentration into a daily volume.
Why do men choose enclomiphene over TRT injections at all?
This is the real question underneath the dosing question, so it's worth answering straight. Exogenous testosterone (TRT) replaces what your testicles make. It works, but it also shuts down the hypothalamic-pituitary-gonadal axis, since your brain senses testosterone is already high and stops sending the signals (LH and FSH) that tell your testicles to keep producing sperm and their own testosterone. That's why TRT is strongly associated with reduced sperm production and testicular shrinkage over time. Enclomiphene works upstream instead. It's a selective estrogen receptor modulator (SERM) that blocks estrogen receptors at the hypothalamus. Your brain reads that as 'estrogen is low,' so it keeps pumping out GnRH, which drives LH and FSH, which keeps your testicles producing both testosterone and sperm. A 2021 review in the World Journal of Men's Health on enclomiphene for secondary hypogonadism describes it as maintaining 'testicular function and spermatogenesis' rather than suppressing it, which is the central mechanistic reason men interested in fertility gravitate toward it [5]. That contrast, testosterone up while gonadotropins stay engaged, is the entire pitch for enclomiphene over injectable TRT for men who still want to have kids or who don't want their testicles to shrink. But be careful with the word 'preserving.' The evidence supports enclomiphene maintaining LH, FSH, and testicular size better than exogenous testosterone does in the studies that exist. It does not amount to a guarantee of any specific fertility outcome for any individual man, and nobody should be told otherwise.
Is enclomiphene FDA-approved, and does that affect dosing guidance?
No. Enclomiphene is not FDA-approved as a standalone medication. Repros Therapeutics developed it under the name Androxal, ran it through Phase III trials for secondary hypogonadism, and the program never reached FDA approval before the company dissolved in 2018 [2]. Every enclomiphene product sold today, including whatever you'd get through a compounding pharmacy, is a compounded preparation, not an FDA-approved generic or brand drug. That matters for dosing in a very concrete way: there is no FDA-reviewed package insert with an approved dosing table to defer to. The 12.5-25mg range you'll see everywhere, including in this article, traces back to trial protocols and prescriber consensus, not a label. Compounded drugs are regulated differently than approved ones. The FDA's own guidance on compounding explains that compounded drugs 'are not FDA-approved' and have 'not been verified for safety, effectiveness, or quality before they are marketed' . That doesn't mean compounded enclomiphene is unsafe or that prescribers are guessing blindly. It means the burden of individualized dosing, based on your labs and your response, falls more heavily on your prescriber than it would with an approved drug. It also means sourcing matters: a compounding pharmacy that isn't following USP standards or isn't state-licensed is a different risk profile than one that is.
How do you know if your dose is working, what labs matter?
Total testosterone is the obvious first check, typically drawn 4-6 weeks after starting or changing dose. But total T alone doesn't tell the whole fertility-preservation story. LH and FSH are the markers that show whether your pituitary is still signaling your testicles normally, and estradiol matters too, since enclomiphene's mechanism runs through estrogen receptor blockade. If you're tracking the fertility angle specifically, a semen analysis is the only test that actually measures sperm production directly. Bloodwork showing preserved LH and FSH is a reasonable proxy, but it's not the same as a semen analysis confirming sperm count and motility are where you'd want them. Most clinics recheck labs at 6-8 weeks, then every 3-6 months once you're stable. If testosterone comes back too high or too low at the 12.5mg starting dose, that's the point where a prescriber typically adjusts toward 25mg or considers every-other-day dosing rather than guessing at a bigger jump.
What side effects show up at different enclomiphene doses?
The most commonly reported side effects across SERM use generally include mood changes, headache, and in some men, visual disturbances, though this last one is more associated with clomiphene and its long-acting zuclomiphene isomer than with enclomiphene specifically [3]. Estradiol shifts can also bring on some of the same symptoms men associate with low or high estrogen on TRT: mood swings, libido changes, water retention. Dose-related side effect data specifically for enclomiphene is limited, since the drug never completed the FDA review process that would normally generate a detailed adverse event profile on a package insert. What exists comes from the Phase III trial data Repros published and from post-market experience at compounding clinics, which isn't systematically collected the way FDA adverse event reporting is for approved drugs. If side effects show up, they're usually a dose or estradiol conversation with your prescriber rather than a reason to self-adjust. Because these are compounded products without a standardized label, the honest move is to report anything unusual and let bloodwork guide the next step, not a forum thread.
How long does an enclomiphene cycle typically run?
This varies more than dosing does. Some men use enclomiphene short-term, a few months, to restart natural production after coming off TRT (a post-cycle-style bridge). Others use it as a longer-term, ongoing alternative to TRT, staying on it for a year or more with periodic lab checks. There isn't a single validated 'cycle length' backed by long-term outcome trials, because the drug's largest trials were the Phase III Androxal studies aimed at a 3-6 month treatment window for regulatory purposes, not lifelong maintenance data [1]. Anyone using it longer term is, by definition, in territory the original trials didn't directly study. For a full breakdown of how cycle length decisions get made in practice, see Enclomiphene Direct cycle length.
Where does the dosing evidence actually come from, and where does it run out?
It's worth being blunt about the evidence base here, because a lot of what's written about enclomiphene dosing online sounds more certain than it is. The strongest data point is the Repros Phase III program comparing 12.5mg and 25mg daily doses against placebo and against testosterone gel in men with secondary hypogonadism, which is registered on ClinicalTrials.gov [1]. That trial found enclomiphene raised testosterone into normal range while better preserving LH, FSH, and sperm parameters compared to topical testosterone, according to the trial's published objectives and Repros' own trial summaries. What's thinner: long-term safety data beyond the trial window, standardized compounded dosing across pharmacies, and head-to-head data against clomiphene at matched doses in men. A lot of the '12.5 to 25mg' number you'll see repeated across clinic websites is a reasonable, trial-anchored starting point, not proof that it's the optimal dose for every man's biology. If you want a genuinely useful next step for figuring out your own numbers rather than a generic range, a dosage calculator built around common compounded concentrations is more practical than trying to eyeball conversions from a liquid vial.
How do you get a legitimate enclomiphene prescription and where does it get filled?
Because enclomiphene isn't FDA-approved as a standalone drug, you can't walk into a retail pharmacy and fill a standard prescription for it the way you would for, say, generic testosterone cypionate. It has to come through a licensed prescriber who works with a compounding pharmacy, and the quality of that pharmacy matters more than it would for an approved generic, since there's no FDA pre-market review backing it up. Enclomiphene Direct's model is provider-reviewed: a licensed prescriber evaluates your labs and history before anything ships, and the prescription is filled by a compounding pharmacy partner rather than manufactured or compounded by Enclomiphene Direct itself. That distinction is worth understanding regardless of where you get your prescription. Whoever you use, ask directly whether the pharmacy is state-licensed and whether it follows USP compounding standards, since that's the closest thing to a quality floor in a market without FDA approval backing the product.
What's the honest bottom line on enclomiphene dosing?
12.5mg to 25mg daily, oral, checked against labs at 6-8 weeks, is the trial-anchored starting range almost every legitimate protocol converges on. There's no FDA label to fall back on because Androxal never got approved, so every number here traces back to Repros' Phase III trials or to what compounding prescribers have learned since [1][2]. The fertility angle is real and mechanistically sound, enclomiphene keeps LH and FSH signaling active in a way exogenous testosterone doesn't, but 'preserves fertility better than TRT' is not the same claim as 'guarantees your sperm count stays normal.' Nobody running a men's health clinic honestly should promise you that outcome. What they can promise is a mechanism that keeps your own axis running instead of shutting it off, and a dose range with real trial data behind it, even if that trial never crossed the finish line to approval.
Frequently asked questions
What is the standard starting dose for enclomiphene?
Most protocols start at 12.5mg daily, based on the dose Repros Therapeutics tested in Phase III Androxal trials for secondary hypogonadism. Some men move to 25mg if labs show testosterone hasn't reached target range after 6-8 weeks. There's no FDA-approved label dose since the drug never won approval, so this range comes from trial data and prescriber consensus, not an official package insert.
Is enclomiphene the same as clomiphene?
No. Clomiphene citrate is a mixture of two isomers, enclomiphene (trans-clomiphene) and zuclomiphene. Enclomiphene is believed to do most of the testosterone-raising work and clears the body faster, while zuclomiphene has a longer half-life and accumulates with repeated dosing, which is linked to more mood and visual side effect concerns with clomiphene over time.
Does enclomiphene preserve fertility better than TRT?
Mechanistically, yes: enclomiphene keeps LH and FSH signaling active, which TRT suppresses, so it maintains the hormonal pathway sperm production depends on. But this is not the same as a guaranteed fertility outcome for any individual man. Semen analysis, more than bloodwork, is the only direct way to confirm sperm production is unaffected.
Is enclomiphene FDA-approved?
No. Enclomiphene was developed as Androxal by Repros Therapeutics, completed Phase III trials for secondary hypogonadism, but never received FDA approval. Repros dissolved as a company in 2018. Everything sold today as enclomiphene is a compounded product, not an FDA-approved drug, which means no official label or standardized dosing table exists.
How often do you take enclomiphene, daily or every other day?
Daily is the more common starting schedule, matching how it was studied in Phase III trials. Some prescribers shift patients to every-other-day dosing once testosterone stabilizes in range, though this isn't backed by a dedicated trial comparing the two schedules head to head. It's a clinical judgment call made with follow-up labs, not a standardized protocol.
Can you take enclomiphene as an injection instead of a pill?
Enclomiphene is fundamentally an oral compound; it was studied and is overwhelmingly dispensed as a capsule or oral solution. Some compounding pharmacies may offer injectable versions, but this isn't the standard route and isn't what the clinical trial data reflects. If your protocol includes injectable compounds separately, injection technique differs entirely from oral enclomiphene dosing.
How long does it take for enclomiphene to raise testosterone?
Most protocols recheck labs at 4-6 weeks after starting, since that's roughly when testosterone response stabilizes in trial data. Some men notice symptom changes (energy, libido) sooner, but bloodwork at 6-8 weeks is the more reliable marker prescribers use to decide whether to hold the dose or adjust it.
What side effects come with enclomiphene?
Reported effects include mood changes, headache, and estradiol-related symptoms like libido shifts or water retention. Visual disturbances are more associated with clomiphene's long-acting zuclomiphene isomer than with isolated enclomiphene. Dose-specific side effect data is limited since enclomiphene never completed FDA review, so the adverse event profile isn't as thoroughly documented as an approved drug's would be.
How long should an enclomiphene cycle last?
There's no single validated cycle length. Some men use it short-term (a few months) as a bridge after stopping TRT; others stay on it long-term as an ongoing alternative, with labs checked every 3-6 months. The original Phase III trials were structured around a 3-6 month window, so longer-term use extends beyond what that specific trial data covers.
Why isn't enclomiphene sold as an approved generic drug?
Repros Therapeutics ran enclomiphene through Phase III trials under the name Androxal but the program never reached FDA approval before the company dissolved in 2018. Without an approved New Drug Application, there's no generic pathway either. Everything available now is compounded by licensed pharmacies working from a prescriber's order, not manufactured under FDA approval.
What labs should you check while on enclomiphene?
Total testosterone, LH, FSH, and estradiol are the core panel, usually rechecked 4-6 weeks after starting or adjusting dose, then every 3-6 months once stable. LH and FSH specifically show whether the pituitary signaling that drives natural testosterone and sperm production is still intact, which is the whole point of choosing enclomiphene over exogenous TRT.
Is compounded enclomiphene safe if it's not FDA-approved?
Compounded doesn't automatically mean unsafe, but it does mean no FDA pre-market review of that specific product's safety or effectiveness. The FDA states compounded drugs 'have not been verified for safety, effectiveness, or quality' before marketing. Choosing a state-licensed pharmacy that follows USP compounding standards is the main safeguard available in this regulatory gap.
Sources
- ClinicalTrials.gov, Repros Therapeutics Phase III enclomiphene (Androxal) trial: Phase III trials tested 12.5mg and 25mg daily doses of enclomiphene in men with secondary hypogonadism
- U.S. Securities and Exchange Commission, Repros Therapeutics corporate filings: Repros Therapeutics dissolved in 2018 without obtaining FDA approval for Androxal
- National Library of Medicine, StatPearls: Clomiphene: Zuclomiphene has a longer half-life and accumulates with repeated dosing, linked to visual and mood side effects
- FDA, Clomiphene Citrate prescribing information: Clomiphene citrate is FDA-approved for female infertility, not for male hypogonadism
- U.S. Food and Drug Administration, Human Drug Compounding: Compounded drugs are not FDA-approved and have not been verified for safety, effectiveness, or quality before marketing